Tim Jasper Knotnerus insider trades
Open-market stock purchases and sales by Tim Jasper Knotnerus, Chief Executive Officer at AgomAb Therapeutics NV, from SEC Form 4 filings since Oct 5, 2026.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +8%.
Companies traded
- AGMB AgomAb Therapeutics NV: 2 buys, last Oct 6, 2026
Get free alerts when Tim Jasper Knotnerus files a new trade →